FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4293491634> ?p ?o ?g. }

• W4293491634 endingPage "39" @default.
• W4293491634 startingPage "34" @default.
• W4293491634 abstract "We aimed to evaluate the current status of first-line treatment options for prostate cancer in patients aged ≥75 years in Korea. The study included 873 patients diagnosed with biopsy-proven prostate cancer at 5 institutions in Korea from January 2009 to December 2018. Inclusion criteria were aged ≥75 years at diagnosis, prostate biopsy with ≥12 cores, and follow-up period ≥1 year. Clinical data were retrospectively collected from electronic medical records. Primary treatment for prostate cancer in patients aged ≥75 years included androgen deprivation therapy (ADT) (n = 614), radical prostatectomy (RP) (n = 114), and radiation therapy (n = 62). Among patients with RP, nine patients received ADT before RP. The RP group was younger with better Eastern Cooperative Oncology Group Performance Status (ECOG PS), lower initial prostate-specific antigen (PSA), Gleason score (GS), max percent positive cores, less positive cores, and less advanced clinical Tumor Node Metastasis (TNM) stage compared with the ADT group. Multivariate analysis showed that age, ECOG PS, and PSA were independent prognostic factors for RP. When the ADT group was classified by therapeutic regimens, the most common therapeutic regimen was maximal androgen blockade (MAB) (n = 571), and leuprolide + bicalutamide (n = 330) was the most common MAB regimen. Multivariate analysis for secondary treatment showed that age, ECOG PS, GS, and clinical N1 or M1 stage were independent predictive factors. Enzalutamide was the most preferred treatment for tertiary treatment. In patients with prostate cancer aged ≥75 years, the most common treatment option was MAB, and the leuprolide + bicalutamide was the most common MAB regimen. Age, ECOG PS, and PSA are the useful indicators of surgical treatment, which increased during the study period. Younger patients with high GS and advanced clinical stage were more likely to undergo secondary treatment." @default.
• W4293491634 created "2022-08-29" @default.
• W4293491634 creator A5002726375 @default.
• W4293491634 creator A5006865956 @default.
• W4293491634 creator A5007281563 @default.
• W4293491634 creator A5008863767 @default.
• W4293491634 creator A5026216541 @default.
• W4293491634 creator A5035019823 @default.
• W4293491634 creator A5039520888 @default.
• W4293491634 creator A5040631515 @default.
• W4293491634 creator A5044649134 @default.
• W4293491634 creator A5044840923 @default.
• W4293491634 creator A5045756626 @default.
• W4293491634 creator A5051087755 @default.
• W4293491634 creator A5059498390 @default.
• W4293491634 creator A5060964400 @default.
• W4293491634 creator A5064188991 @default.
• W4293491634 creator A5073820694 @default.
• W4293491634 creator A5080340707 @default.
• W4293491634 creator A5080820818 @default.
• W4293491634 creator A5081458527 @default.
• W4293491634 creator A5091355368 @default.
• W4293491634 date "2023-03-01" @default.
• W4293491634 modified "2023-10-05" @default.
• W4293491634 title "Current treatment patterns within 1 year after prostate cancer diagnosis in Korean patients over 75 years old: a retrospective multicenter study" @default.
• W4293491634 cites W2020286047 @default.
• W4293491634 cites W2115409203 @default.
• W4293491634 cites W2151180605 @default.
• W4293491634 cites W2342743778 @default.
• W4293491634 cites W2460408780 @default.
• W4293491634 cites W2598023545 @default.
• W4293491634 cites W2784290558 @default.
• W4293491634 cites W2883055473 @default.
• W4293491634 cites W2953000753 @default.
• W4293491634 cites W2953448950 @default.
• W4293491634 cites W2993046989 @default.
• W4293491634 cites W3008672214 @default.
• W4293491634 cites W3010723440 @default.
• W4293491634 cites W3086028987 @default.
• W4293491634 cites W3158075485 @default.
• W4293491634 cites W3201343768 @default.
• W4293491634 cites W4220871460 @default.
• W4293491634 cites W4220919673 @default.
• W4293491634 doi "https://doi.org/10.1016/j.prnil.2022.08.003" @default.
• W4293491634 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36910903" @default.
• W4293491634 hasPublicationYear "2023" @default.
• W4293491634 type Work @default.
• W4293491634 citedByCount "1" @default.
• W4293491634 countsByYear W42934916342023 @default.
• W4293491634 crossrefType "journal-article" @default.
• W4293491634 hasAuthorship W4293491634A5002726375 @default.
• W4293491634 hasAuthorship W4293491634A5006865956 @default.
• W4293491634 hasAuthorship W4293491634A5007281563 @default.
• W4293491634 hasAuthorship W4293491634A5008863767 @default.
• W4293491634 hasAuthorship W4293491634A5026216541 @default.
• W4293491634 hasAuthorship W4293491634A5035019823 @default.
• W4293491634 hasAuthorship W4293491634A5039520888 @default.
• W4293491634 hasAuthorship W4293491634A5040631515 @default.
• W4293491634 hasAuthorship W4293491634A5044649134 @default.
• W4293491634 hasAuthorship W4293491634A5044840923 @default.
• W4293491634 hasAuthorship W4293491634A5045756626 @default.
• W4293491634 hasAuthorship W4293491634A5051087755 @default.
• W4293491634 hasAuthorship W4293491634A5059498390 @default.
• W4293491634 hasAuthorship W4293491634A5060964400 @default.
• W4293491634 hasAuthorship W4293491634A5064188991 @default.
• W4293491634 hasAuthorship W4293491634A5073820694 @default.
• W4293491634 hasAuthorship W4293491634A5080340707 @default.
• W4293491634 hasAuthorship W4293491634A5080820818 @default.
• W4293491634 hasAuthorship W4293491634A5081458527 @default.
• W4293491634 hasAuthorship W4293491634A5091355368 @default.
• W4293491634 hasBestOaLocation W42934916341 @default.
• W4293491634 hasConcept C121608353 @default.
• W4293491634 hasConcept C126322002 @default.
• W4293491634 hasConcept C143998085 @default.
• W4293491634 hasConcept C2776235491 @default.
• W4293491634 hasConcept C2777899217 @default.
• W4293491634 hasConcept C2779466945 @default.
• W4293491634 hasConcept C2780192828 @default.
• W4293491634 hasConcept C2780962315 @default.
• W4293491634 hasConcept C2781406297 @default.
• W4293491634 hasConcept C2781413609 @default.
• W4293491634 hasConcept C61367390 @default.
• W4293491634 hasConcept C71924100 @default.
• W4293491634 hasConceptScore W4293491634C121608353 @default.
• W4293491634 hasConceptScore W4293491634C126322002 @default.
• W4293491634 hasConceptScore W4293491634C143998085 @default.
• W4293491634 hasConceptScore W4293491634C2776235491 @default.
• W4293491634 hasConceptScore W4293491634C2777899217 @default.
• W4293491634 hasConceptScore W4293491634C2779466945 @default.
• W4293491634 hasConceptScore W4293491634C2780192828 @default.
• W4293491634 hasConceptScore W4293491634C2780962315 @default.
• W4293491634 hasConceptScore W4293491634C2781406297 @default.
• W4293491634 hasConceptScore W4293491634C2781413609 @default.
• W4293491634 hasConceptScore W4293491634C61367390 @default.
• W4293491634 hasConceptScore W4293491634C71924100 @default.
• W4293491634 hasFunder F4320321250 @default.
• W4293491634 hasIssue "1" @default.
• W4293491634 hasLocation W42934916341 @default.

• next